Replimune Group, Inc. Business Finance Contracts & Agreements

29 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Registration Rights Agreement, dated March 5, 2025, by and among the Company and 667, L.P. and Baker Brothers Life Sciences, L.P
Registration Rights Agreements
Replimune Group, Inc.
Biotechnology
2025
Form of Pre-Funded Warrant
Warrant Agreements
Replimune Group, Inc.
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
Replimune Group, Inc.
Biotechnology
NY
2024
Underwriting Agreement dated November 25, 2024
Underwriting Agreements
Replimune Group, Inc.
Biotechnology
NY
2024
Form of U.K. Inducement Restricted Stock Unit Grant Agreement
Stock Agreements
Replimune Group, Inc.
Biotechnology
DE
2024
Form of U.K. Inducement Stock Option Grant Agreement
Stock Agreements
Replimune Group, Inc.
Biotechnology
DE
2024
Form of Registration Rights Agreement
Registration Rights Agreements
Replimune Group, Inc.
Biotechnology
2024
Securities Purchase Agreement, dated June 12, 2024, by and among Replimune Group, Inc. and each of the investors as party thereto
Purchase Agreements
Replimune Group, Inc.
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
Replimune Group, Inc.
Biotechnology
NY
2024
Form of Inducement Restricted Stock Unit Grant Agreement
Stock Agreements
Replimune Group, Inc.
Biotechnology
MA
2024
Form of Inducement Stock Option Grant Agreement
Stock Agreements
Replimune Group, Inc.
Biotechnology
DE
2024
Second Amendment to Loan and Security Agreement, dated as of December 22, 2023, by and among Replimune Group Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc
Loan Agreements
Replimune Group, Inc.
Biotechnology
NY
2024
Restricted Stock Unit
Stock Agreements
Replimune Group, Inc.
Biotechnology
MA
2023
Stock Option Grant Agreement, effective as of
Stock Agreements
Replimune Group, Inc.
Biotechnology
DE
2023
Restricted Stock Unit Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant
Stock Agreements
Replimune Group, Inc.
Biotechnology
MA
2023
Stock Option Grant Agreement, effective as of December 30, 2022, by and between Christopher Sarchi and the Registrant
Stock Agreements
Replimune Group, Inc.
Biotechnology
DE
2023
Form of Pre-Funded Warrant
Warrant Agreements
Replimune Group, Inc.
Biotechnology
NY
2022
Underwriting Agreement dated December 8, 2022
Underwriting Agreements
Replimune Group, Inc.
Biotechnology
NY
2022
Restricted Stock Unit Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant
Stock Agreements
Replimune Group, Inc.
Biotechnology
MA
2021
Stock Option Grant Agreement, effective as of May 3, 2021, by and between Sushil Patel and the Registrant
Stock Agreements
Replimune Group, Inc.
Biotechnology
DE
2021
Payoff Letter to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated December 15, 2020
Loan Agreements
Replimune Group, Inc.
Biotechnology
CA
2021
Underwriting Agreement dated October 21, 2020
Underwriting Agreements
Replimune Group, Inc.
Biotechnology
NY
2020
Form of Pre-Funded Warrant
Warrant Agreements
Replimune Group, Inc.
Biotechnology
NY
2020
Underwriting Agreement dated June 8, 2020
Underwriting Agreements
Replimune Group, Inc.
Biotechnology
NY
2020
First Amendment to Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated June 1, 2020
Loan Agreements
Replimune Group, Inc.
Biotechnology
CA
2020
Form of Pre-Funded Warrant
Warrant Agreements
Replimune Group, Inc.
Biotechnology
NY
2019
Underwriting Agreement dated November 14, 2019
Underwriting Agreements
Replimune Group, Inc.
Biotechnology
NY
2019
Loan and Security Agreement by and among Replimune Group, Inc., Replimune, Inc., Replimune Limited and Hercules Capital, Inc., dated August 7, 2019
Loan Agreements
Replimune Group, Inc.
Biotechnology
DE
2019
Description of Capital Stock
Stock Agreements
Replimune Group, Inc.
Biotechnology
2019